IDIX Financial Facts
Collaboration revenue - related party: -26.07MNet loss: -64.46M
See Full Income Statement
Accumulated other comprehensive income: 783K
Total current liabilities: 28.26M
See Full Balance Sheet
Idenix Pharmaceuticals Inc. (IDIX) Earnings
|
Expand Research on IDIX
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -31.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +2.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 7/31/14 | Q214 | -$0.43 | -$0.21 | -$0.22 | N/A | $50K | N/A |  | | Details | |
| 5/1/14 | Q114 | -$0.24 | -$0.19 | -$0.05 | N/A | $220K | N/A | | | Details | |
2/27/14  |
Q413 | -$0.17 | -$0.22 | +$0.05 | $500K | $150K | N/A | | | Details | |
| 10/30/13 | Q313 | -$0.25 | -$0.21 | -$0.04 | N/A | $560K | N/A | | | Details | |
| 2/25/13 | Q412 | -$0.17 | -$0.17 | $0.00 | $327K | $740K | N/A | | | Details | |
| 11/1/12 |
 |
Q312 | $0.03 | -$0.17 | +$0.20 | $32.3M | $2.6M | N/A | | | Details |
| 2/23/12 |
|
Q411 | -$0.18 | -$0.14 | -$0.04 | N/A | $3.07M | N/A | | | Details |
| 11/2/11 |
|
Q311 | -$0.12 | -$0.15 | +$0.03 | $2.64M | $2.56M | N/A | | | Details |
